XML 48 R38.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Summary of Stock Option Assumptions
The following weighted average assumptions were used to determine the fair value of the stock options granted on the original grant date for expense recognition purposes for options granted during the three months ended March 31, 2022 and 2021 using a Black Scholes-Merton Model:
 Three months ended
 March 31, 2022March 31, 2021
Directors and SLT1:
  
Expected dividend rate$0.38$0.38
Expected volatility35.87%35.78%
Risk-free interest rate2.11%0.50%
Expected life (in years)4.04.0
Employees:  
Expected dividend rate$0.38$0.38
Expected volatility37.16%38.70%
Risk-free interest rate1.98%0.30%
Expected life (in years)3.03.0
1 Senior Leadership Team ("SLT") consists of officers and key members of management.
The following weighted average assumptions were used to determine the fair value of the PSUs granted on the original grant date for expense recognition purposes for PSUs granted during the three months ended March 31, 2022 and 2021 using a Monte Carlo Model:
 Three months ended
 March 31, 2022March 31, 2021
 
Expected dividend rate$0.38$0.38
Expected volatility37.60%39.10%
Risk-free interest rate2.00%0.28%
Expected life (in years)2.802.81
Summary of Stock Options Outstanding
The following is a summary of stock options vested and exercisable as of March 31, 2022:

 
Range of
Exercise
Prices
Number
of
Shares
Weighted
Average
Remaining
Contractual Life
(in years)
Weighted
Average
Exercise
Price
Intrinsic
Value
(in thousands)
$8.17 -$41.37 1,323,510 5.73$36.12 $25,953 
$42.42 -$65.24 271,925 7.8244.72 3,005 
$65.29 -$79.81 101,868 8.8673.22 — 
Total1,697,303 6.25$39.72 $28,958 
 
The following is a summary of stock options vested and exercisable as of March 31, 2021:
Range of
Exercise
Prices
Number
of
Shares
Weighted
Average
Remaining
Contractual Life
(in years)
Weighted
Average
Exercise
Price
Intrinsic
Value
(in thousands)
$7.18 -$40.87 621,552 5.58$30.01 $24,863 
$41.37 -$41.37 427,899 7.8641.37 12,255 
$41.78 -$75.00 143,232 8.7544.45 3,661 
Total1,192,683 6.78$35.82 $40,779 
Summary of Stock Option Activity
A summary of stock option activity under the plans is as follows:

Stock OptionsSharesWeighted
Average
Exercise
Price
Outstanding at December 31, 2021
3,365,469 $42.88 
Granted
353,723 54.52 
Exercised
(79,169)36.51 
Forfeited or Expired
(25,288)51.58 
Outstanding at March 31, 2022
3,614,735 $44.10 
Exercisable at March 31, 2022
1,697,303 $39.72 
Summary of Unvested Restricted Stock Awards
A summary of the unvested restricted stock awards is as follows:

SharesWeighted
Average
Grant Date
Fair Value
Unvested at December 31, 2021
161,225 $46.08 
Granted
39,903 53.55 
Vested
(48,479)42.20 
Forfeited
(581)49.75 
Unvested at March 31, 2022
152,068 $49.26 
Schedule of Nonvested Key Employee Award Activity
A summary of the unvested Key Employee Awards is as follows:

SharesWeighted
Average
Grant Date
Fair Value
Unvested at December 31, 2021
26,599 $80.18 
Granted
— — 
Vested
— — 
Forfeited
— — 
Unvested at March 31, 2022
26,599 $80.18 
Schedule of Nonvested Performance-based Units Activity
A summary of the unvested PSUs is as follows:
SharesWeighted
Average
Grant Date
Fair Value
Unvested at December 31, 2021
16,851 $87.78 
Granted
41,621 44.74 
Vested
— — 
Forfeited
— — 
Unvested at March 31, 2022
58,472 $57.14 
Summary of Share-Based Compensation Expense
A summary of share-based compensation is as follows:

Three Months Ended
 March 31,
2022
March 31,
2021
Grant date fair value of awards during the period:(in thousands)
Options$4,849 $6,513 
Performance awards1,862 1,506 
Restricted stock2,137 1,400 
Total$8,848 $9,419 
Share-based compensation expense:
Options$2,040 $2,163 
Performance awards185 41 
Restricted stock679 557 
Key employee awards208 — 
Total$3,112 $2,761 
Income tax benefit/(deficiency) related to share-based compensation:
Options$293 $2,295 
Restricted stock219 615 
Total$512 $2,910